{"id":"W2557622830","doi":"10.1182/blood.v124.21.4472.4472","title":"Results of a Phase 2 Study of MEDI-551 and Bendamustine Vs Rituximab and Bendamustine in Relapsed or Refractory Chronic Lymphocytic Leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; University of Toronto; Jewish General Hospital","funders":"","keywords":"Bendamustine; Rituximab; Medicine; Chronic lymphocytic leukemia; Internal medicine; Neutropenia; Population; Fludarabine; Adverse effect; Gastroenterology; Tolerability; Leukemia; Immunology; Chemotherapy; Lymphoma; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004465377,0.001703493,0.002579506,0.0004363698,0.0004498942,0.001074308,0.0009895123,0.001665681,0.004074758],"category_scores_gemma":[0.002522,0.0008148953,0.002061128,0.0003701654,0.001059943,0.001110499,0.0003908337,0.003105472,0.0008365473],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001223158,"about_ca_system_score_gemma":0.001570283,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000878032,"about_ca_topic_score_gemma":0.001622555,"domain_scores_codex":[0.9984745,0.0009759375,0.00008467657,0.0002008961,0.0001188409,0.0001452151],"domain_scores_gemma":[0.9980142,0.0006515364,0.0003616455,0.0002006174,0.0001401974,0.0006318245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.920353,0.04568444,0.001337372,0.0002602018,0.001122082,0.00006771193,0.000103089,0.0008810813,0.01186077,0.000080322,0.0007495267,0.01750035],"study_design_scores_gemma":[0.5669809,0.4228094,0.005307146,0.0000222243,0.0009299619,0.00009006965,0.00003264677,0.0006492837,0.00202091,0.000128724,0.001000389,0.00002846044],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929413,0.001665756,0.0004964573,0.0003791254,0.0001300481,0.002315216,0.0009825947,0.00005199705,0.001037668],"genre_scores_gemma":[0.9865362,0.001595469,0.001914885,0.0009606902,0.0003279002,0.003218601,0.003039526,0.00003268641,0.002374031],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004465377,"threshold_uncertainty_score":0.02361542,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02092777761060369,"score_gpt":0.3141411403582586,"score_spread":0.2932133627476549,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}